PFHO has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PFHO has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Pacific Health Care Organization Inc PFHO
Pacific Health Care Organization PFHO 51 Peter Lynch Fair Value is $1.01 as of Jul. 11, 2026, which is 13% below its 10-year median of 1.16. GuruFocus rates PFHO with a GF Score™ of 51/100 and a GF Value™ of $0.94 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 4 Healthcare Plans companies, Pacific Health Care Organization ranks worse than 75% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, Pacific Health Care Organization's PEG is 1. Pacific Health Care Organization's 5-Year TTM EBITDA Growth Rate is 9.15. Pacific Health Care Organization's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was $0.11. Therefore, the Peter Lynch Fair Value for today is $1.01.
As of today (2026-07-11), Pacific Health Care Organization's share price is $0.83. Pacific Health Care Organization's Peter Lynch fair value is $1.01. Therefore, Pacific Health Care Organization's Price to Peter Lynch Fair Value Ratio for today is 0.82.
The historical rank and industry rank for Pacific Health Care Organization's Peter Lynch Fair Value or its related term are showing as below:
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of Pacific Health Care Organization was 2.23. The lowest was 0.28. And the median was 1.16.
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
Pacific Health Care Organization (OTCPK:PFHO) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 9.15 instead of 15 in this case.
Pacific Health Care Organization's Price to Peter Lynch Fair Value Ratio for today is calculated as
| Price to Peter Lynch Fair Value | = | Share Price | / | Peter Lynch Fair Value |
| = | 0.83 | / | 1.01 | |
| = | 0.82 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The historical data trend for Pacific Health Care Organization's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| Pacific Health Care Organization Annual Data | |||||||||||||||||||||
| Trend | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | Dec24 | Dec25 | |||||||||||
| Peter Lynch Fair Value | Get a 7-Day Free Trial |
|
|
0.00 | 0.00 | 0.00 | 0.00 | 0.95 | |||||||||||||
| Pacific Health Care Organization Quarterly Data | ||||||||||||||||||||
| Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | Jun24 | Sep24 | Dec24 | Mar25 | Jun25 | Sep25 | Dec25 | Mar26 | |
| Peter Lynch Fair Value | Get a 7-Day Free Trial |
|
|
|
|
|
|
|
|
|
|
|
|
0.00 | 0.00 | 0.73 | 0.95 | 1.01 | ||
For the Healthcare Plans subindustry, Pacific Health Care Organization's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Pacific Health Care Organization's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where Pacific Health Care Organization's Price-to-Peter-Lynch-Fair-Value falls into.
Pacific Health Care Organization's Peter Lynch Fair Value for today is calculated as
| Peter Lynch Fair Value | = | PEG Ratio | * | 5-Year TTM EBITDA Growth Rate** | * | EPS without NRI (TTM) |
| = | 1 | * | 9.15 | * | 0.11 | |
| = | 1.01 |
Pacific Health Care Organization's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.11.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
Based on GuruFocus' analysis, Pacific Health Care Organization stock appears to be undervalued. The current stock price of $0.83 is trading 11.7% below its estimated GF Value™ of $0.94. GuruFocus considers Pacific Health Care Organization to be Modestly Undervalued.
Key valuation signals for PFHO:
No single metric tells the full story. See the PFHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.